KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

McEwen (MUX) Research & Development (2016 - 2025)

McEwen has reported Research & Development over the past 14 years, most recently at $6.3 million for Q4 2025.

  • Quarterly results put Research & Development at $6.3 million for Q4 2025, up 168.63% from a year ago — trailing twelve months through Dec 2025 was $22.2 million (up 34.15% YoY), and the annual figure for FY2025 was $22.2 million, up 34.15%.
  • Research & Development for Q4 2025 was $6.3 million at McEwen, down from $6.8 million in the prior quarter.
  • Over the last five years, Research & Development for MUX hit a ceiling of $6.9 million in Q2 2021 and a floor of $2.4 million in Q4 2024.
  • Median Research & Development over the past 5 years was $4.8 million (2021), compared with a mean of $4.8 million.
  • Biggest five-year swings in Research & Development: tumbled 37.93% in 2022 and later soared 168.63% in 2025.
  • McEwen's Research & Development stood at $4.5 million in 2021, then decreased by 21.08% to $3.5 million in 2022, then rose by 5.65% to $3.7 million in 2023, then tumbled by 36.86% to $2.4 million in 2024, then skyrocketed by 168.63% to $6.3 million in 2025.
  • The last three reported values for Research & Development were $6.3 million (Q4 2025), $6.8 million (Q3 2025), and $5.4 million (Q2 2025) per Business Quant data.